Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–40. https://doi.org/10.1136/gutjnl-2016-313589.

Article  PubMed  Google Scholar 

Tuppin P, Rivière S, Deutsch D, et al. Burden of drug use for gastrointestinal symptoms and functional gastrointestinal disorders in France: a national study using reimbursement data for 57 million inhabitants. Therap Adv Gastroenterol. 2019;12(12):175628481985379. https://doi.org/10.1177/1756284819853790.

Article  Google Scholar 

Katz PO, Dunbar K, Schnoll-Sussman FH, et al. ACG clinical guideline: guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2023;117(1):27–56. https://doi.org/10.14309/ajg.0000000000001538.

Article  Google Scholar 

Zielinski R, Searing K, Deibel M. Gastrointestinal distress in pregnancy: prevalence, assessment, and treatment of 5 common minor discomforts. J Perinatal Neonatal Nurs. 2015;29:23–31. https://doi.org/10.1097/JPN.0000000000000078.

Article  Google Scholar 

Engeland A, Bjørge T, Klungsøyr K, et al. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiol Drug Saf. 2018;27:995–1004. https://doi.org/10.1002/pds.4577.

Article  PubMed  Google Scholar 

Gerbier E, Graber SM, Rauch M, et al. Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data. Swiss Med Wkly. 2021;151: w30048. https://doi.org/10.4414/SMW.2021.w30048.

Article  CAS  PubMed  Google Scholar 

Meyer A, Fermaut M, Drouin J, et al. Drug use for gastrointestinal symptoms during pregnancy: a French nationwide study 2010–2018. PLoS ONE. 2021;16: e0245854. https://doi.org/10.1371/journal.pone.0245854.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child. 2018;103:78–82. https://doi.org/10.1136/archdischild-2017-314026.

Article  PubMed  Google Scholar 

Vilcu A-M, Sabatte L, Blanchon T, et al. Association between acute gastroenteritis and continuous use of proton pump inhibitors during winter periods of highest circulation of enteric viruses. JAMA Netw Open. 2019;2: e1916205. https://doi.org/10.1001/jamanetworkopen.2019.16205.

Article  PubMed  PubMed Central  Google Scholar 

Dipasquale V, Cicala G, Spina E, Romano C. A narrative review on efficacy and safety of proton pump inhibitors in children. Front Pharmacol. 2022;13: 839972. https://doi.org/10.3389/fphar.2022.839972.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lassalle M, Zureik M, Dray-Spira R. Proton pump inhibitor use and risk of serious infections in young children. JAMA Pediatr. 2023;177(10):1028–38. https://doi.org/10.1001/jamapediatrics.2023.2900.

Article  PubMed  PubMed Central  Google Scholar 

Cohen S, Bueno de Mesquita M, Mimouni FB. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review: gastroesophageal reflux disease in children. Br J Clin Pharmacol. 2015;80:200–8. https://doi.org/10.1111/bcp.12619.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006;117:e817–20. https://doi.org/10.1542/peds.2005-1655.

Article  PubMed  Google Scholar 

Shakhnovich V, Ward RM, Kearns GL. Failure of proton pump inhibitors to treat gerd in neonates and infants: a question of drug, diagnosis, or design. Clin Pharmacol Ther. 2012;92:388–92. https://doi.org/10.1038/clpt.2012.86.

Article  CAS  PubMed  Google Scholar 

Eze P, Balsells E, Kyaw MH, Nair H. Risk factors for Clostridium difficile infections—an overview of the evidence base and challenges in data synthesis. J Glob Health. 2017;7: 010417. https://doi.org/10.7189/jogh.07.010417.

Article  PubMed  PubMed Central  Google Scholar 

Moroishi Y, Gui J, Hoen AG, et al. The relationship between the gut microbiome and the risk of respiratory infections among newborns. Commun Med. 2022;2:87. https://doi.org/10.1038/s43856-022-00152-1.

Article  PubMed  PubMed Central  Google Scholar 

Nakitanda AO, Kieler H, Odsbu I, et al. In-utero antibiotic exposure and subsequent infections in infancy: a register-based cohort study with sibling analysis. Am J Obstetr Gynecol MFM. 2023;5: 100860. https://doi.org/10.1016/j.ajogmf.2023.100860.

Article  CAS  Google Scholar 

Miller JE, Wu C, Pedersen LH, et al. Maternal antibiotic exposure during pregnancy and hospitalization with infection in offspring: a population-based cohort study. Int J Epidemiol. 2018;47:561–71. https://doi.org/10.1093/ije/dyx272.

Article  PubMed  Google Scholar 

Bezin J, Duong M, Lassalle R, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954–62. https://doi.org/10.1002/pds.4233.

Article  PubMed  Google Scholar 

Blotière P-O, Weill A, Dalichampt M, et al. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: an application to antiepileptic drug use in 4.9 million pregnant women in France. Pharmacoepidemiol Drug Saf. 2018;27:763–70. https://doi.org/10.1002/pds.4556.

Article  PubMed  PubMed Central  Google Scholar 

Collins A, Weitkamp J-H, Wynn JL. Why are preterm newborns at increased risk of infection? Arch Dis Child Fetal Neonatal Ed. 2018;103:F391–4. https://doi.org/10.1136/archdischild-2017-313595.

Article  PubMed  Google Scholar 

Ukah UV, Aibibula W, Platt RW, et al. Time-related biases in perinatal pharmacoepidemiology: a systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2022;31(12):1228–41. https://doi.org/10.1002/pds.5504.

Article  PubMed  Google Scholar 

Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167:492–9. https://doi.org/10.1093/aje/kwm324.

Article  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–8. https://doi.org/10.1136/bmj.39335.541782.AD.

Article  Google Scholar 

Sahli L, Lapeyre-Mestre M, Derumeaux H. Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database. Pharmacoepidemiol Drug Saf. 2016;25(7):785–9. https://doi.org/10.1002/pds.4006.

Article  PubMed  Google Scholar 

Meyer A, Taine M, Drouin J, et al. Serious infections in children born to mothers with inflammatory bowel disease with in utero exposure to thiopurines and anti-tumor necrosis factor. Clin Gastroenterol Hepatol. 2022;20:1269-1281.e9. https://doi.org/10.1016/j.cgh.2021.07.028.

Article  CAS  PubMed  Google Scholar 

Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797. Obstet Gynecol. 2020;135(2):e51-e72. 535 https://doi.org/10.1097/AOG.0000000000003668. Erratum in: Obstet Gynecol. 2020;135(4):978-979.536

National Collaborating Centre for Women's and Children's Health (UK). Antibiotics for Early-Onset Neonatal Infection: Antibiotics for the Prevention and Treatment of Early-Onset Neonatal Infection. London: RCOG Press; 2012 Aug. PMID: 23346609.

Ghosn W. Indicateurs écologiques synthétiques du niveau socio-économique pour la recherche en Santé. 2018. https://www.cepidc.inserm.fr/sites/default/files/2020-11/Note_indices_socioeco-2.pdf. Accessed 25 June 2023.

Sinha A, Yokoe D, Platt R. Epidemiology of neonatal infections: experience during and after hospitalization. Pediatr Infect Dis J. 2003;22:244–50. https://doi.org/10.1097/01.inf.0000055060.32226.8a.

Article  PubMed  Google Scholar 

Ferreras-Antolín L, Oligbu G, Okike IO, Ladhani S. Infection is associated with one in five childhood deaths in England and Wales: analysis of national death registrations data, 2013–15. Arch Dis Child. 2020;105:857–63. https://doi.org/10.1136/archdischild-2019-318001.

Article  PubMed  Google Scholar 

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9. Erratum in: Lancet. 2020;396(10262):1562. https://doi.org/10.1016/S0140-6736(20)32226-1

Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev. 2010;23:74–98. https://doi.org/10.1128/CMR.00032-09.

Article